3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Agnosia
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Kidney Neoplasms
1
Ileus
1
Head and Neck Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Curative Breast Cancer Surgery
1
Constipation
1
Colonic Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Acute Pain
1
Interventions
aldesleukin
42
Sunitinib
39
Cyclophosphamide
30
Nivolumab
27
Everolimus
27
pembrolizumab
26
Interferon-alpha
25
Bevacizumab
22
Sorafenib
21
Interleukin-2
20
fludarabine phosphate
19
Filgrastim
18
Ipilimumab
17
Radiotherapy
16
Axitinib
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
fludarabine
11
Radiosurgery
11
Doxorubicin
11
Carboplatin
11
temsirolimus
10
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
belzutifan
8
atezolizumab
8
Fluorouracil
8
pazopanib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Kidney Neoplasms
×
Ketorolac Tromethamine
×
Clear all
NCT05842044
2025-09-05
No-PAIN
University of Miami
Phase 2
Recruiting
110 enrolled